ClinicalTrials.Veeva

Menu

Acute Diverticulitis and Advanced Colonic Neoplasia. When to Perform Colonoscopy (ADACOLON Study)

P

Parc de Salut Mar

Status

Completed

Conditions

Colonic Neoplasms
Diverticulitis, Colonic

Treatments

Diagnostic Test: Fecal immunochemical and occult blood test
Diagnostic Test: Colonoscopy
Diagnostic Test: Fecal calprotectin test

Study type

Interventional

Funder types

Other

Identifiers

NCT03557216
ADACOLON

Details and patient eligibility

About

This study evaluate the prevalence of advanced colonic neoplasia (ACN) in acute diverticulitis. A sub-analysis of complicated and uncomplicated acute diverticulitis will be made in order to determinate whether there are differences of advanced colonic neoplasia (ANC) prevalence in both groups and to assess if a colonoscopy is necessary.

Full description

This is a prospective study that eliminates biases in the selection, design and variability of retrospective studies to reliably assess the global prevalence of advanced colon neoplasia (ACN) and the difference in prevalence among populations with complicated and uncomplicated acute diverticulitis diagnosed by computed tomography. Another objective is to assess the diagnostic prediction of computed tomography to detect ACN in acute diverticulitis. It also aims to assess the safety and quality of colonoscopy in a patient recently diagnosed with acute diverticulitis. Finally, it aims to study whether other diagnostic tools such as the presence of clinical risk symptoms or the performance of fecal biological tests could help in narrowing the indication of colonoscopy in this clinical scenario.

Enrollment

313 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

All patients consecutively diagnosed with acute diverticulitis in the participating hospitals during the study inclusion period will be included. For this purpose, a multidetector computerized tomography confirming the diagnosis of acute diverticulitis must be performed on all patients with initial clinical suspicion.

Exclusion criteria

  1. Patient refusal to participate in the study.
  2. Impossibility of obtaining informed consent by the patient or guardian.
  3. Age <18 years and> 85 years
  4. Impossibility of performing a diagnostic CT of AD.
  5. Intercurrent medical or surgical process with prolonged recovery in time that prevents a colonoscopy before 6 months after the resolution of the episode of acute diverticulitis.

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

313 participants in 2 patient groups

Complicated diverticulitis
Experimental group
Description:
Patients with complicated diverticulitis diagnosed by computed tomography. Colonoscopy, Fecal immunochemical and occult blood test (FIT) and fecal calprotectin test wil be performed.
Treatment:
Diagnostic Test: Colonoscopy
Diagnostic Test: Fecal calprotectin test
Diagnostic Test: Fecal immunochemical and occult blood test
Uncomplicated diverticulitis
Experimental group
Description:
Patients with uncomplicated diverticulitis diagnosed by computed tomography. Colonoscopy, Fecal immunochemical and occult blood test (FIT) and fecal calprotectin test wil be performed.
Treatment:
Diagnostic Test: Colonoscopy
Diagnostic Test: Fecal calprotectin test
Diagnostic Test: Fecal immunochemical and occult blood test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems